Bacteriophages and Host Recognition
Why can a virus infect only one bacterial species, sometimes only one strain? Meanwhile a chemical poison kills almost anything it touches. The answer lies in a single, exquisitely specific handshake. It occurs between a virus and a molecule on its host's surface. Bacteriophages ("phages") are viruses that infect bacteria and archaea. They are the most abundant biological entities on Earth. An estimated 10³¹ particles exist in the biosphere. This outnumbers bacteria roughly ten to one. Understanding how a phage finds, recognizes, and commits to a host cell matters greatly. It is the gateway to understanding everything that follows in a viral infection. This recognition step is called adsorption. It is not a passive collision. Instead, it is a structured, multi-stage molecular event. Dedicated viral appendages carry it out — tail fibers, tail spikes, base plates. These appendages read the chemical Braille of the bacterial cell envelope. The specificity of this interaction is so absolute that phages are used diagnostically to "type" bacterial strains. It is so consequential that bacteria evolve receptor mutations purely to escape it. The receptor a phage uses determines which hosts it can enter. Because of this, adsorption is the single most important determinant of host range. Host range in turn shapes everything from natural microbial ecology to the feasibility of phage therapy in a hospital ward. This article builds on the general logic of Virus Structure and Symmetry. It asks how that structure is put to functional use. We survey phage diversity and the anatomy of the tailed phage. This is the dominant morphotype in nature. Then we walk through the biophysics of adsorption step by step. These steps are diffusion, reversible binding, irreversible binding, and the triggering of genome ejection. We then examine the classical experiments. These proved phages are particulate, host-specific agents recognizing discrete surface receptors. This work is ultimately traceable to Twort, d'Herelle, and later Delbrück's quantitative one-step experiments. The article closes at the threshold of infection proper. It sets up The Lytic Cycle and The Lysogenic Cycle.
- Bacteriophages are viruses of bacteria and archaea; tailed phages (order Caudovirales lineage, now split into several families) dominate numerically and structurally.
- Host recognition happens via adsorption: a phage's tail fibers or spikes bind specific receptor molecules on the bacterial surface — proteins, LPS, teichoic acids, pili, or flagella.
- Adsorption has two kinetically distinct phases: rapid, reversible initial contact, followed by slower, essentially irreversible tight binding that commits the phage to infection.
- Receptor specificity, not merely capsid geometry, is the principal molecular basis of phage host range and strain specificity.
- Classic experiments (Ellis & Delbrück's one-step growth curve, Hershey & Chase's blender experiment) used adsorption as an experimental handle to prove phages inject DNA and stay outside as an empty coat.
- Modern applications include phage typing, phage therapy against multidrug-resistant bacteria, receptor-binding-protein engineering, and phage display biotechnology.
A bacteriophage recognizes its host not by cell type in general but by binding a specific, often mutable, surface molecule with a dedicated tail structure, and this single molecular handshake — adsorption — is what defines the phage's host range.
The core idea
A bacteriophage is a virus whose only natural hosts are prokaryotes — bacteria or archaea. Like all viruses, a phage is an obligate intracellular parasite: a protein (sometimes lipid-containing) shell called a capsid enclosing a genome of DNA or RNA, single- or double-stranded, that carries no independent metabolism and cannot reproduce outside a living cell. Phages show enormous morphological diversity, but the classical, still-dominant morphotype pictured in every textbook is the tailed phage: an icosahedral (or prolate) head storing double-stranded DNA, connected through a portal vertex to a tail that ends in a receptor-binding apparatus. Other major groups include cubic (polyhedral, tailless) phages, filamentous phages, and pleomorphic or spindle-shaped phages typical of archaeal viruses; these differences in capsid architecture were introduced under Virus Structure and Symmetry and recur here as the chassis on which host-recognition machinery is mounted. The concept this article is built around is adsorption: the process by which a phage particle attaches to a susceptible bacterial cell prior to genome delivery. Adsorption is receptor-mediated, meaning it depends on a specific molecular complementarity between a viral attachment protein and a defined chemical structure on the host envelope — not a generic "stickiness." The bacterial molecule involved is called the phage receptor, and it is virtually always a molecule the bacterium needs for its own physiology (a nutrient transporter, a component of the cell wall, a flagellum, a pilus) rather than something evolved for the virus's benefit. This is a crucial conceptual point: the bacterium cannot simply discard the receptor, because doing so costs fitness, which is why receptor loss is only one of several imperfect resistance strategies bacteria use against phage predation.
Host range — the set of bacterial species or strains a given phage can infect — is determined primarily, though not exclusively, by receptor compatibility at the adsorption step, together with subsequent intracellular barriers such as restriction-modification systems and CRISPR-Cas immunity (topics that belong properly to The Lytic Cycle and The Lysogenic Cycle). Because receptors vary chemically between species, and even between strains of one species (different capsular polysaccharides, different O-antigen sugars on lipopolysaccharide), phage host ranges are often narrow — frequently limited to one species or even a handful of strains within a species. This narrowness is both the frustration and the promise of phage biology: frustrating for anyone trying to find a single phage that treats an infection regardless of strain, promising for anyone who wants a therapeutic that leaves the rest of the microbiome untouched.
Mechanism
Anatomy of the tailed phage
The tailed phage is built from a small number of structural modules, each with a distinct job. The head (capsid) is an icosahedral protein shell, typically 50–200 nm across, that packages the double-stranded DNA genome under enormous internal pressure — measured directly by atomic force microscopy to reach tens of atmospheres, comparable to a car tire, in phages such as λ and T7. The portal is a dodecameric protein ring at one capsid vertex through which DNA is pumped in during assembly and later exits during infection. The tail connects to the portal; in Myoviridae-type phages (e.g., T4) it is long, rigid, and contractile, sheathed around an inner tube; in Siphoviridae-type phages (e.g., λ) it is long and flexible, non-contractile; in Podoviridae-type phages (e.g., T7) it is short, almost stub-like. At the distal tip sits the baseplate, a multiprotein complex bearing tail fibers and/or tail spikes — the actual receptor-recognition organelles. T4, the best-studied tailed phage, illustrates the division of labor concretely. Its baseplate carries six long tail fibers (built largely from the gene product 37 protein) that make the first, reversible contact with the host, and six short tail fibers that, once triggered, irreversibly lock onto the cell surface. The long tail fibers behave almost like antennae, scanning for the receptor lipopolysaccharide and outer membrane protein OmpC on Escherichia coli. Binding of the long fibers signals the baseplate to change conformation from a dome shape to a star shape, which in turn triggers contraction of the outer sheath, driving the inner tube through the outer membrane like a molecular syringe.
Step-by-step adsorption
Step 1 — Diffusion and random collision. Phage particles have no active motility; they move by Brownian diffusion in the surrounding fluid. Collision with a bacterium is therefore a matter of chance, governed by phage concentration, bacterial concentration, and diffusion coefficients. The rate of successful collisions can be described by a second-order rate law: dP/dt = −k · P · B where P is the free phage concentration, B is the bacterial concentration, and k is the adsorption rate constant (units of mL·min⁻¹, since concentrations are per mL). Measured values of k typically fall in the range of 10⁻⁹ to 10⁻⁸ mL/min per bacterium for well-adapted phage–host pairs, meaning a phage in a dense bacterial culture (~10⁸ cells/mL) adsorbs with a half-time of only a few minutes.
Step 2 — Reversible attachment. Initial contact between a tail fiber and a receptor is weak and reversible — the phage can detach and continue diffusing if the encounter is unproductive or if it strikes a non-permissive site. This stage is analogous to the initial, low-affinity "rolling" contact in other receptor-ligand systems: it allows the phage to sample many surface sites without committing.
Step 3 — Irreversible attachment. If the correct receptor is engaged with the correct geometry, a conformational change locks the tail structure onto the cell surface. In T4, this is the long-fiber-triggered baseplate reorganization described above; in many Siphoviridae, it is a conformational cascade in the tail tip complex (e.g., the gp9/gpJ machinery of λ, which engages the maltose transporter LamB). Irreversible attachment is essentially a point of no return: detachment now would mean the phage's genome-delivery apparatus has already begun to act.
Step 4 — Genome ejection. The irreversibly bound tail creates or opens a channel across the outer membrane, peptidoglycan layer, and inner membrane. Internal capsid pressure, combined in some phages with host-cell metabolic energy and phage or host proteins pulling DNA through the channel, drives the linear (or circular, depending on the phage) genome out of the capsid and into the host cytoplasm, while the empty protein coat remains outside. This "genome-in, coat-out" separation is the single most important physical fact about tailed-phage infection, and it is precisely what the Hershey–Chase experiment (below) was designed to reveal.
Receptors: the chemistry of specificity
The receptor determines everything about host range, and different phages have evolved to read entirely different molecular "words" on the bacterial surface:
| Receptor class | Example bacterium | Example phage | Chemical nature |
|---|---|---|---|
| Lipopolysaccharide (LPS) O-antigen | E. coli, Salmonella | T3, T4 (via LPS core), P22 | Repeating sugar polymer on outer membrane |
| Outer membrane protein | E. coli K-12 | T4 (OmpC), λ (LamB) | Integral β-barrel porins/transporters |
| Teichoic acid | Staphylococcus aureus, Bacillus subtilis | phage φ29-related, many Siphoviridae | Cell wall polymer, Gram-positive envelope |
| Capsular polysaccharide | Klebsiella pneumoniae | Depolymerase-bearing phages | Thick extracellular sugar coat |
| Flagellum | Vibrio, Salmonella, E. coli | Chi phage | Rotating protein filament |
| Pilus (conjugative) | F⁺ E. coli | M13, MS2, Qβ (male-specific phages) | Extracellular tube for DNA transfer |
Because many of these molecules are essential for nutrient uptake (LamB imports maltose), motility (flagella), or conjugation (pili), the bacterium faces a genuine cost-benefit tradeoff in mutating them away to escape phage predation — a tension central to the coevolutionary arms race between phages and bacteria, and a preview of the resistance mechanisms discussed alongside The Lysogenic Cycle.
From binding to commitment: a kinetic view
Adsorption's two-phase character (reversible then irreversible) can be visualized as a dose-response-like curve of infectivity over time. Immediately after mixing phage and bacteria, the fraction of free (unadsorbed) phage falls exponentially, and the shape of that decay — plotted as the classic "adsorption curve" — is one of the first quantities measured for any newly isolated phage, because the adsorption rate constant k is a defining biological parameter almost as fundamental as burst size or latent period (both covered under The Lytic Cycle).
The evidence
Twort, d'Herelle, and the discovery of a particulate agent
The existence of bacteriophages was demonstrated independently by Frederick Twort (1915) and Félix d'Herelle (1917). Twort observed that colonies of micrococci on agar sometimes developed transparent, "glassy" degenerating patches that could be transferred to fresh colonies and would keep spreading, passing through bacteria-retaining filters — the classic operational definition of a filterable agent, the same criterion Beijerinck and Ivanovsky had earlier used to define plant viruses. D'Herelle, working independently on dysentery-causing Shigella, showed that filtrates from recovering patients' stool could clear turbid bacterial cultures, producing sharply defined circular clearings — plaques — when spotted onto a lawn of bacteria on solid agar. Critically, d'Herelle showed that the agent multiplied: a small amount added to a bacterial culture yielded far more infectious material afterward, proof that it was a self-replicating biological entity and not a static chemical toxin. He coined the term "bacteriophage" (bacteria-eater) and correctly proposed that these agents attacked bacteria with strict specificity — some filtrates cleared one Shigella strain but not another, an early empirical hint of the receptor specificity later explained mechanistically.
The one-step growth experiment: Ellis and Delbrück (1939)
Max Delbrück and Emory Ellis designed the one-step growth curve experiment specifically to quantify the life cycle of a phage as a population-synchronized process, and adsorption was the experimental lever they used to start the clock. They mixed phage with a large excess of susceptible bacteria for a short period, allowing essentially all free phage particles to adsorb; they then diluted the mixture enormously, so that any newly released phage would be too dilute to immediately reinfect a fresh cell. This trick — synchronizing infection by adsorption, then preventing a second round by dilution — allowed them to plot the number of infectious phage particles (measured as plaque-forming units) over time and observe a latent period with no free phage, followed by a sudden burst releasing many new virions per infected cell (the burst size). This experiment established that phage reproduction is not gradual budding but an all-or-nothing intracellular event, and it depended entirely on adsorption being fast, essentially complete, and treatable as a discrete "time zero" — direct experimental proof that adsorption is a genuine, measurable, rate-limited biological step rather than an instantaneous or negligible one.
The Hershey–Chase blender experiment (1952)
Alfred Hershey and Martha Chase used the physical separability of adsorbed phage — an intact protein coat sitting outside the cell, with genetic material delivered inside — to answer a question left open since Avery, MacLeod, and McCarty's 1944 transformation work: is DNA or protein the hereditary material? They labeled two separate batches of T2 phage: one with radioactive phosphorus (³²P), which is present in DNA's phosphate backbone but essentially absent from protein, and another with radioactive sulfur (³⁵S), present in the sulfur-containing amino acids of protein but absent from DNA. Each labeled phage stock was allowed to adsorb to E. coli for a few minutes — a step that depended entirely on the adsorption mechanism described above, using T2's tail fibers to bind the bacterial surface. The mixture was then agitated violently in a Waring blender, a shearing force sufficient to strip the empty phage coats off the bacterial surface without lysing the cells or disrupting the intracellular infection already underway. The results were unambiguous:
| Labeled component | Where the label ended up |
|---|---|
| ³²P (DNA) | Mostly inside the bacterial cell (pellet) |
| ³⁵S (protein) | Mostly in the fluid, still on empty phage coats (supernatant) |
Centrifugation separated the blended mixture into a bacterial pellet and a supernatant containing detached phage "ghosts." The ³²P-labeled DNA stayed largely with the bacteria, while the ³⁵S-labeled protein was mostly released into the supernatant with the coats. Furthermore, infected bacteria still produced a normal burst of progeny phage even after the empty protein coats were sheared away, proving that the DNA alone carried the information sufficient to redirect the cell and produce new phage. This proved that DNA, not protein, is the hereditary material — and it worked as an experiment only because adsorption physically and mechanically partitions the phage into an external component (the coat) and an internal one (the genome), exactly as described in the mechanism above.
Modern structural confirmation
Cryo-electron microscopy and X-ray crystallography since the 1990s and 2000s have directly visualized baseplate conformational changes (dome-to-star transitions in T4), the atomic structure of the λ tail-tip complex bound to LamB, and single-molecule force measurements of DNA ejection, converting the classical genetic and biochemical inferences above into structurally resolved mechanisms — a case study in how molecular biology confirms and refines, rather than overturns, foundational 20th-century experiments.
Worked examples
Example 1 — Predicting host range from receptor genotype. A clinical microbiology lab isolates a novel lytic phage, "φ-K7," from hospital wastewater and wants to know its likely host range before testing it against a panel of 40 Klebsiella pneumoniae clinical isolates. Structural analysis shows φ-K7's tail carries a large tail-spike protein with depolymerase activity, similar to phages known to degrade specific capsular polysaccharide (K-antigen) types. Reasoning: Because the receptor is a capsular polysaccharide rather than a conserved outer-membrane protein, host range is expected to track capsular (K) serotype rather than species membership as a whole. K. pneumoniae strains are classified into more than 80 distinct K-types based on chemically distinct capsule structures. A depolymerase-tailed phage typically recognizes only one or a few closely related K-types, because the depolymerase active site must fit a specific sugar linkage pattern. Prediction and expected result: Among 40 clinical isolates spanning many K-types, we would predict φ-K7 to productively infect (plaque-form on) only the small subset sharing the matching capsular chemistry — commonly under 20% of a serotype-diverse panel — even though all 40 isolates are the same bacterial species. This is exactly the pattern typically observed for capsule-specific phages, and it is the central practical challenge in phage therapy: a single phage isolate is rarely a "one-size-fits-all" antibacterial, and clinical use generally requires a cocktail of phages with complementary receptor specificities, or a preliminary host-range assay against the patient's specific isolate.
Example 2 — Interpreting an adsorption-rate experiment quantitatively. A student mixes phage T4 (initial titer 2 × 10⁶ PFU/mL) with a growing culture of E. coli at a concentration of 4 × 10⁸ cells/mL. Samples are removed at intervals, bacteria and adsorbed phage are removed by low-speed centrifugation, and the supernatant (containing only free, unadsorbed phage) is titered by the plaque assay. The data:
| Time (min) | Free phage (PFU/mL) |
|---|---|
| 0 | 2.0 × 10⁶ |
| 2 | 8.0 × 10⁵ |
| 4 | 3.2 × 10⁵ |
| 6 | 1.3 × 10⁵ |
Step 1 — Confirm exponential decay. Successive ratios: 8.0×10⁵ / 2.0×10⁶ = 0.40; 3.2×10⁵ / 8.0×10⁵ = 0.40; 1.3×10⁵/3.2×10⁵ ≈ 0.41. The roughly constant ratio per 2-minute interval confirms first-order (exponential) decay in free phage, consistent with the second-order rate law dP/dt = −k·P·B treated as pseudo-first-order because B (bacteria) is essentially constant over this short interval (bacterial doubling time, ~20–30 min, is much longer than the adsorption timescale). Step 2 — Extract the rate constant. Using P(t) = P₀·e^(−kBt), and taking the 0–4 min interval: ln(3.2×10⁵ / 2.0×10⁶) = −kB(4 min), so −1.83 = −kB(4), giving kB ≈ 0.458 min⁻¹. Dividing by B = 4×10⁸ cells/mL: k ≈ 0.458 / (4×10⁸) ≈ 1.1 × 10⁻⁹ mL/min This falls squarely within the textbook range for a well-adapted phage–host pair (10⁻⁹–10⁻⁸ mL/min), telling the student that T4 adsorbs efficiently and rapidly to this E. coli strain — useful confirmation before proceeding to a one-step growth curve to measure latent period and burst size.
Common misconceptions & traps
| Misconception | Why it's wrong |
|---|---|
| "A phage attaches to any part of the bacterial surface." | Attachment is receptor-specific: only tail structures binding a matching molecule (LPS, protein, pilus, flagellum) lead to productive adsorption. |
| "Host range is fixed and defined only by bacterial species." | Host range often tracks strain-level or serotype-level receptor variation (e.g., capsular K-type), so phages can discriminate below the species level. |
| "The phage capsid enters the bacterial cell." | In tailed phages the capsid (coat) stays outside; only the nucleic acid (and sometimes a few internal proteins) is injected — the basis of the Hershey–Chase result. |
| "Adsorption is instantaneous and can be ignored kinetically." | Adsorption has measurable reversible and irreversible phases and a defined rate constant k; it is rate-limiting in real infections and central to one-step growth analysis. |
| "Bacteria can freely lose their receptors to become phage-resistant at no cost." | Most phage receptors are essential host molecules (porins, transporters, pili, flagella); losing them typically imposes a fitness cost, creating an evolutionary trade-off, not a free lunch. |
| "Phage host specificity means phages are dangerous to humans." | Phages recognize only prokaryotic surface receptors absent from human cells; they do not infect human cells, which underlies their safety profile in therapy. |
The scientist behind it
Félix d'Herelle was a largely self-taught, itinerant microbiologist — Canadian-born, based for much of his career at the Pasteur Institute in Paris — whose career defies the stereotype of the credentialed academic scientist. Working on an outbreak of hemorrhagic dysentery among French troops in 1917, he noticed that filtered stool samples, passed through a filter fine enough to exclude bacteria, contained something that produced sharply bounded clear zones ("taches vierges," virgin spots, later called plaques) when spread on a bacterial lawn. He correctly inferred that these clearings represented localized destruction by a self-replicating, transmissible agent — a live "microbe of microbes" — rather than a static toxin, and he devoted much of the rest of his career to characterizing bacteriophages and pioneering their therapeutic use against bacterial disease, decades before antibiotics existed and, in the former Soviet republic of Georgia, continuing in specialized clinical use to this day.
Origins · 1 minFélix d'Herelle and how this was discovered
D'Herelle was a largely self-trained microbiologist who, working on dysentery outbreaks, demonstrated in 1917 that a filterable, self-multiplying agent lysed bacterial cultures in sharply defined plaques. He named the agent "bacteriophage," proposed its use as a living antibacterial therapy, and helped found what became the Eliava Institute in Tbilisi, a center for phage therapy still active today.
Where this matters today
Phage typing and epidemiology. Because phage host range tracks surface receptor chemistry so finely, panels of characterized phages are used to "type" bacterial isolates — a technique long predating genomic sequencing and still used for rapid outbreak tracking of pathogens such as Salmonella and Staphylococcus aureus.
Phage therapy against multidrug-resistant bacteria. As antibiotic resistance spreads, phages are being revisited as precision antibacterials. Because adsorption specificity confines a phage's action to particular strains, phage therapy can in principle spare beneficial commensal microbiota — but this same specificity means therapeutic phages must be matched to a patient's infecting strain, usually via host-range testing or engineered cocktails, exactly as reasoned through in Worked Example 1.
Engineering receptor-binding proteins. Synthetic biologists now swap tail-fiber or tail-spike genes between phages, or engineer them directly, to redirect a phage's host range toward a desired pathogen — for example, broadening or narrowing specificity for Klebsiella or Pseudomonas clinical strains, or building phages that specifically target antibiotic-resistant lineages.
Phage display and biotechnology. Filamentous phages such as M13, which adsorb to the tip of the bacterial F-pilus, are engineered to display foreign peptides or antibody fragments fused to their coat proteins, a technology (phage display) that won the 2018 Nobel Prize in Chemistry and underlies the discovery of many therapeutic antibodies.
Agriculture and food safety. Phage cocktails targeting receptor-defined serotypes of Salmonella, E. coli O157:H7, and Listeria are used as biocontrol agents on produce and in food processing, precisely because their narrow host range avoids disrupting beneficial bacteria in the food or gut microbiome.
Basic ecology and the microbiome. Because adsorption specificity constrains phage-host interactions so tightly, phage predation shapes microbial community structure globally, driving the "kill-the-winner" dynamics thought to maintain diversity in oceans, soils, and the human gut — a topic that connects directly forward to the population-level consequences of The Lytic Cycle and The Lysogenic Cycle.
Ask the tutor: How does a phage's receptor choice constrain or enable its ability to establish lysogeny versus commit to the lytic cycle?
Why are tailed phages considered the "dominant" phage morphotype?
Tailed, dsDNA phages (historically classified as Caudovirales, now split by the International Committee on Taxonomy of Viruses into families such as Straboviridae, Drexlerviridae, and others) constitute the overwhelming majority of phages isolated and sequenced from natural environments, from soil to seawater to the human gut. Their tail apparatus — fibers, spikes, and baseplate — gives them a mechanistically explicit, reusable solution to the problem of specific host recognition and genome delivery, which likely contributed to their evolutionary success and ecological ubiquity. Other morphotypes (filamentous, polyhedral tailless, pleomorphic archaeal viruses) are real and biologically important, especially in archaea and in specific niches like phage display biotechnology (filamentous M13), but numerically and in textbook emphasis, tailed phages dominate.
Is adsorption reversible or irreversible — which is it?
Both, at different stages. Initial contact between a tail fiber and a candidate receptor is weak and reversible: the phage can detach and continue searching if the fit is poor or transient. If the correct receptor is engaged correctly, a conformational change (such as the baseplate dome-to-star transition in T4) locks the phage on irreversibly, committing it to genome ejection. This two-phase kinetic structure — reversible sampling followed by an irreversible commitment step — is a recurring theme in receptor-ligand recognition throughout biology, not unique to phages, and it is exactly what adsorption-rate experiments (as in Worked Example 2) are designed to detect and quantify.
Can a single bacterium be resistant to one phage but susceptible to another?
Yes, routinely. Resistance to a given phage is often receptor-specific: a mutation altering LamB, for instance, blocks phage λ adsorption but has no effect on a phage that uses OmpC or LPS as its receptor. This is precisely why phage therapy formulations typically use cocktails of phages with different receptor specificities — resistance to one component of the cocktail does not confer resistance to the others, at least not through the same mechanism, though cross-resistance can occur if multiple phages happen to share a receptor.
How does adsorption specificity relate to the CRISPR-Cas and restriction-modification systems covered under lytic/lysogenic cycles?
Adsorption is the first and most upstream barrier a phage must clear: without receptor binding and genome injection, no infection can even begin. Restriction-modification systems and CRISPR-Cas immunity act later, after the phage genome is already inside the cytoplasm, degrading unmethylated or previously "remembered" foreign DNA sequences. A bacterium can therefore resist phage infection at two conceptually separate levels — preventing entry (receptor modification, discussed here) or destroying the genome after entry (intracellular immunity, discussed under The Lytic Cycle and The Lysogenic Cycle) — and real bacterial populations typically deploy both layers together.
Why does phage host specificity make phage therapy both promising and difficult?
Specificity is promising because a well-matched phage kills only the target pathogen, sparing the patient's normal microbiota — a sharp contrast with broad-spectrum antibiotics, which can devastate beneficial gut flora and select for resistance across many species at once. It is difficult because that same specificity means a single phage isolate often works against only a fraction of clinical strains of a given pathogen species, as illustrated in Worked Example 1 with Klebsiella capsular serotypes. Clinical phage therapy therefore usually requires strain-matching diagnostics before treatment, or the use of phage cocktails and continuously updated phage banks, adding logistical complexity relative to a shelf-stable antibiotic.
What experimental technique is used to measure a phage's adsorption rate constant?
Researchers mix a known titer of phage with a known, much larger concentration of exponentially growing bacteria, then remove samples at timed intervals and separate bacteria (with adsorbed phage) from the fluid by low-speed centrifugation or filtration. The remaining free phage in the supernatant is quantified by the plaque assay, and the decline in free phage titer over time is fit to an exponential decay model to extract the rate constant k, as demonstrated numerically in Worked Example 2. This measurement is one of the first characterizations performed on any newly isolated phage, alongside determining its latent period and burst size in a one-step growth curve.
Does receptor binding alone guarantee successful infection?
No. Adsorption is necessary but not sufficient. Even after a phage irreversibly attaches and injects its genome, the infection can still be blocked by intracellular defenses such as restriction endonucleases that cut unmethylated phage DNA, CRISPR-Cas systems that recognize and cleave previously encountered phage sequences, or abortive-infection systems that sacrifice the infected cell before progeny phage can be produced. Adsorption defines which cells a phage can physically enter, but the outcome of that entry — successful lytic replication, lysogeny, or abortive failure — depends on downstream molecular events covered under The Lytic Cycle and The Lysogenic Cycle.